Profile
International Journal of Clinical & Medical Microbiology Volume 2 (2017), Article ID 2:IJCMM-119, 9 pages
https://doi.org/10.15344/2456-4028/2017/119
Research Article
Quinolone Resistance Detection by PCR-RFLP and Multiplex-PCR among Extended- Spectrum β- Lactamase Producing Enterobacteriaceae

Marry Khalil1, Rasha Elsherif2, Doaa Ghaith2, Dalia K. Ismail2, Sara Mohamed1, Samyah Jastaniah3, Mohamed Nabil Alama4 and Gamal Karrouf 5,6*

1Botany and Microbiology Department, Faculty of Science, Cairo University
2Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University
3Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
4Consultant Adult Interventional Cardiologist, King Abdulaziz Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia
5Faculty of Science, Medical Physics Department, King Abdulaziz University, Jeddah 21589, Saudi Arabia
6Surgery, Anaesthesiology and Radiology Department, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516 Dakahlia, Egypt
Prof. Gamal Karrouf, Faculty of Science, Medical Physics Department, King Abdulaziz University, 21589Jeddah, Saudi Arabia and Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516 Dakahlia, Egypt; E-mail: gkarrouf@kau.edu.sa
13 January 2016; 07 March 2017; 09 March 2017
Khalil M, Elsherif R, Ghaith D, Ismail DK, Mohamed S, et al. (2017) Quinolone Resistance Detection by PCR-RFLP and Multiplex-PCR among Extended- Spectrum β- Lactamase Producing Enterobacteriaceae. Int J Clin Med Microbiol 2: 119. doi: https://doi.org/10.15344/2456-4028/2017/119

References

  1. Falagas ME, Karageorgopoulos DE, Nordmann P (2011) Therapeutic options for infections with Enterobacteriaceae producing carbapenemhydrolyzing enzymes. Future Microbiol 6: 653-666 [CrossRef] [Google Scholar] [PubMed]
  2. Poole K (2003) Overcoming multidrug resistance in gram-negative bacteria. Curr Opin Investig Drugs 4: 128-139 [CrossRef] [Google Scholar] [PubMed]
  3. Ball P (2000) Quinolone generations: natural history or natural selection? J Antimicrob Chemother 46 Suppl T1: 17-24 [CrossRef] [Google Scholar] [PubMed]
  4. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill 13 [Google Scholar] [PubMed]
  5. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmidmediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22: 664-689 [CrossRef] [Google Scholar] [PubMed]
  6. Robicsek A, Jacoby GA, Hooper DC (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629-640 [CrossRef] [Google Scholar] [PubMed]
  7. Alonso R, Mateo E, Girbau C, Churruca E, Martinez I, et al. (2004) PCRRestriction Fragment Length Polymorphism Assay for Detection of gyrA Mutations Associated with Fluoroquinolone Resistance in Campylobacter coli. Antimicrobial Agents and Chemotherapy 48: 4886-4888 [CrossRef] [Google Scholar] [PubMed]
  8. Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [CrossRef] [Google Scholar] [PubMed]
  9. Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-1117 [CrossRef] [Google Scholar] [PubMed]
  10. Fadli M, Chevalier J, Saad A, Mezrioui NE, Hassani L, et al. (2011) Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria. Int J Antimicrob Agents 38: 325-330 [CrossRef] [Google Scholar] [PubMed]
  11. Lamers RP, Cavallari JF, Burrows LL (2013) The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAßN) permeabilizes the outer membrane of gram-negative bacteria. PLoS One 8: 3 [CrossRef] [Google Scholar] [PubMed]
  12. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing. M100-S20. CLSI, Wayne, PA
  13. Yedekci S, Erac B, Limoncu MH (2012) Detection Of The Efflux Pump- Mediated Quinolone Resistance In ESBL Positive Escherichia Coli And Klebsiella Pneumoniae Isolates by Phe-Arg-?eta Naphthylamide. Turk J Pharm Sci 9: 67-74 [Google Scholar]
  14. Kim HB, Park CH, Kim CJ, Kim, EC, Jacoby, GA, et al. (2009a) Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period. Antimicrobial Agents Chemother 53: 639-645 [CrossRef] [Google Scholar] [PubMed]
  15. Wang Y, Huang WM, Taylor DE (1993) Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.Antimicrob. Agents Chemother 37: 457-463 [CrossRef] [Google Scholar] [PubMed]
  16. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, et al. (2009b) oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 53: 3582-3584 [CrossRef] [Google Scholar] [PubMed]
  17. Mohajeri P, Darfarin G, Farahani A (2014) Genotyping ofESBL-producing Uropathogenic Escherichia coli in West of Iran. International Journal of Microbiology 2014: 276941 [CrossRef] [Google Scholar] [PubMed]
  18. Helaly GF, Abou-Shleib H, Fanaki NH, Abdel-Kader O, Ali GH (2010) Potential Co-prevalence of Plasmid-Mediated Quinolone Resistance Determinant qepA and 16S rRNA Methylase rmtB among E.coli Clinical Isolates from Alexandria- Egypt. J Egy Pub Health Assoc 85: 247-272 [Google Scholar] [PubMed]
  19. Lunn, AD, Fàbrega, A, Sánchez-Céspedes J, Vila J (2010) Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. Clinical isolates. Int Microb 13: 15-20 [CrossRef] [Google Scholar] [PubMed]
  20. Glatz KMD (2012) Antimicrobial susceptibility and molecular epidemiology of drug resistant bacterial pathogens of healthcare-associated infections, Doctoral thesis [Google Scholar]
  21. Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, et al. (2011) Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin Microbiol Infect 18: 539-545 [CrossRef] [Google Scholar] [PubMed]
  22. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC (2006) Prevalence in the United States of aac(6’)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953-3955 [CrossRef] [Google Scholar] [PubMed]
  23. Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo, JD, et al. (2007) Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. Int J Antimicrob Agents 29: 402-9 [CrossRef] [Google Scholar] [PubMed]
  24. Hassan WM, Hashim A, Domany R (2012) Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol 30: 442-447 [CrossRef] [Google Scholar] [PubMed]
  25. Paiva MC, Nascimento AMA, Camargo ILBC, Lima-Bittencourt CI, Nardi RMD (2012) The first report of the qnrB19, qnrS1 and aac(6´)-Ib-cr genes in urinary isolates of ciprofloxacin-resistant Escherichia coli in Brazil. Mem Inst Oswaldo Cruz 107: 687-689 [CrossRef] [Google Scholar] [PubMed]
  26. Perichon B, Courvalin P, Galimand M (2007) Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother 51: 2464-2469 [CrossRef] [Google Scholar] [PubMed]
  27. Perez F, Rudin S, Marshall S, Chen L, Coakley P, et al. (2013) OqxAB, a Quinolone and Olaquindox Efflux Pump, Is Widely Distributed among Multidrug-Resistant Klebsiella pneumoniae Isolates of Human Origin. Antimicrob Agents Chemother 57: 4602-4603 [CrossRef] [Google Scholar] [PubMed]
  28. Taherpour A, Hashemi A (2013) Detection of oqxAB efflux pumps, OmpK35 and OmpK36 porins in extended-spectrum-ß-lactamase-producing Klebsiella pneumoniae isolates from Iran. Hippokratia 17: 355-358 [Google Scholar] [PubMed]